πŸ‡ΊπŸ‡Έ FDA
Patent

US 11623929

Spirocyclic compounds

granted A61PA61P35/00

Quick answer

US patent 11623929 (Spirocyclic compounds) held by C4 THERAPEUTICS, INC. expires Mon Apr 06 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
C4 THERAPEUTICS, INC.
Grant date
Tue Apr 11 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 06 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61P, A61P35/00